Navigation Links
Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
Date:10/19/2007

y assigned to either of the MIRCERA arms or to continue epoetin alfa or beta at their current dose and administration interval. Patients randomized to MIRCERA received a starting dose based on the previous weekly dose of epoetin.

In contrast to previous studies in which dialysis patients were converted from IV epoetin using sequential increases in dosing intervals, most patients in MAXIMA were converted directly from a predominantly three-times-a-week regimen of epoetin (87 percent of patients) to IV MIRCERA administered once every two weeks or once every four weeks.

MAXIMA Study Findings

The MAXIMA results showed:

-- Minute changes in Hb levels throughout the duration of the study (mean

changes from the baseline to the evaluation periods were -0.71, -0.25,

and -0.75 g/L in the MIRCERA once every two weeks; MIRCERA once every

four weeks and epoetin groups, respectively), illustrating that the

primary efficacy parameter (mean change in Hb level between baseline

and evaluation periods) was met.

-- For the secondary analysis, the proportion of patients maintaining a

mean Hb within plus or minus 10 g/L of baseline was 68 percent, 68

percent, and 67 percent in the MIRCERA once every two weeks and MIRCERA

once every four weeks and epoetin groups, respectively.

-- The most common serious adverse events in the three groups were sepsis,

pneumonia and arteriograft thrombosis. A similar incidence of adverse

events occurred across all treatment arms with the most frequent

adverse events mild to moderate and had a distribution typical for this

patient population.

About MIRCERA

The clinical program for MIRCERA consisted of 10 global studies involving more than 2,700 patients from 29 countries. The Phase III program for MIRCERA included two correction studies and four maintenance studies exploring intravenous (IV) and subcuta
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
2. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
5. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
6. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
7. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
9. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
10. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
11. Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... BALTIMORE and LONDON , Aug. 28, ... volunteers in the UK, The Gambia and ... of an series of safety trials of potential vaccines aimed at ... the current outbreak in West Africa . ... US National Institutes of Health (NIH) and GlaxoSmithKline, are to be ...
(Date:8/28/2014)... CHARLOTTE, N.C. , Aug. 28, 2014 /PRNewswire/ ... innovation marketplace, today announced a worldwide search for ... of the senior population.  Promising ideas uncovered through ... presented to leading medical device manufacturers and healthcare ... to improve the lives of individuals age 65 ...
(Date:8/28/2014)... 28, 2014 According to a ... Identification (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) ... Forecast, 2014 - 2020" the global radiofrequency identification (RFID) ... and is expected to grow at a CAGR of ... value of USD 5.3 billion in 2020. ...
Breaking Medicine Technology:Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... 16, 2010 See video from Siemens Corporation ... Say so-long to the days of black ... to MRI and PET, medical imaging is faster, ... way medicine is practiced. Thanks to years of ...
... Unsustainable Medicare reimbursement rates for home medical equipment ... providers will occur as a result of Medicare,s bidding ... nine of the largest metropolitan areas in the U.S. ... Dallas-Fort Worth, Kansas City, Miami, Orlando, Pittsburgh, and Riverside, ...
Cached Medicine Technology:VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 2Problems Emerge in Competitive Bidding Pricing Scheme for Home Medical Equipment; Economists Predict the Program Will Fail 3
(Date:8/28/2014)... A subset of patients with stage III colon ... therapy, according to a new study in ... the American Gastroenterological Association. , When added to the ... irinotecan therapy improved overall survival rates for patients with ... in about 10 to 20 percent of colorectal cancers. ...
(Date:8/28/2014)... over who identify themselves as ,old, feel worse about ... have lower value than younger age groups. , New ... ,Being old and ill, across different countries: social status, ... from the European Social Survey. Respondents, who were all ... health., The researchers found that those living in societies ...
(Date:8/28/2014)... Manchester scientists are working out how to safely increase ... potentially offering improved local control and survival. , Standard ... a combination of radiotherapy and chemotherapy. Traditionally this is ... may not always be enough to stop tumour growth. ... the cancerous tissue varies between patients and depends on ...
(Date:8/28/2014)... 2014 Vaccine market - the once ... among other healthcare industry sectors and sub-circles in the ... vaccine with respect to evolving and spreading infectious diseases. ... an improved understanding for a well-balanced life and improved ... has led to new opportunities for manufacturing novel preventive ...
(Date:8/28/2014)... August 28, 2014 AmeriPride Services, a ... today announced the launch of its new Customer Portal, ... even easier and more convenient for customers. The industry-leading ... and better communicate with the company. , Features of ... Access, download and pay bills online ...
Breaking Medicine News(10 mins):Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Research demonstrates potential method to better control lung cancer using radiotherapy 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3
... The Medicare drug program is on its last lap of seeking ... of the plans to rest// with three major insurance players. ... with AARP as its official endorsers and a financial agreement with ... for the drug program by Medicare. ,80 companies have ...
... have been found to be alive in America today. ... management of the disease. // ,However it has ... do suffer from debilitating fatigue making normal activities of life ... California at Los Angeles found that not all survivors suffer ...
... included bestowing nurses and pharmacists with the right to ... and pharmacists can undertake extra training in order to ... to tonsillitis. ,Many nurses already run their ... prescribe drugs even for long-term conditions such as asthma ...
... action against smoking in Scotland, it would stop sales of tobacco ... it. ,Ministers have not decided whether to back the ... determination to reduce smoking rates in Scotland. ,In the ... a member of the expert group, "Smoking is far worse than ...
... non-typical sleep times has the ability to improve an ... Sleep Medicine at Brigham and Women’s Hospital and Harvard ... in order to find out the effectiveness of melatonin. ... travelers with jet lag. br> ,The findings appear in ...
... say that percutaneous image-guided biopsy is of a great ... accurately// diagnosing and predicting clinical outcomes. The researchers arrived ... in 126 patients. They found that the biopsy results ... who were to undergo surgery, tumor ablation, chemotherapy or ...
Cached Medicine News:Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Melatonin Can Help Nighttime Workers Sleep 2Health News:Melatonin Can Help Nighttime Workers Sleep 3Health News:Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: